Designed to handle the pressure of the mitral position, the MITRIS RESILIA mitral valve can help you meet the specialised needs of your patients.* The MITRIS RESILIA valve is the latest to join our RESILIA tissue portfolio, which is backed by a strong and growing body of clinical evidence, both in clinical trials and real clinical practice.
We are delighted to share the latest RESILIA tissue research, with insight from expert users.
Discover more on RESILIA tissue through the current and past issues below.
*No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients.
This healthcare professional focused booklet explores the latest clinical studies and publications involving the INSPIRIS RESILIA valve and RESILIA tissue through the review of 24 publications and abstracts.
Each reference has been summarized visually over 1 or 2 slides, for you to save time.
*No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients.
†RESILIA tissue tested against tissue from commercially-available bovine pericardial valves from Edwards in a juvenile sheep model. Flameng, et al. J Thorac Cardiovasc Surg 2015;149:340–5
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
An educational website focused on TAVI is underway
Thank you. We will keep you updated when new content is available.